European nations like Denmark and the U.K. have kept new cases of hepatitis B low. Denmark recorded no cases of ...
Evaxion A/S has announced the initiation of a new vaccine program, EVX-B4, targeting Group A Streptococcus (GAS), a pathogen responsible for a wide range of infections globally, including severe ...
COPENHAGEN, Denmark, November 12, 2024 - Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, announces new ...
NASHVILLE Tenn. (WKRN) — It can take more than a decade to develop a new vaccine for children. After years of research and testing, some don’t pass the safety checks. One laboratory at Vanderbilt ...
Vaccine hesitancy isn’t a moral failure – it’s a property of a system in which people must balance personal and collective ...
The U.S. reportedly plans to overhaul the country’s childhood vaccine schedule. The move could set public health back decades ...
An initiative born at Rutgers University is taking a shot at building vaccine confidence. Founded in March 2023 while longtime Johnson & Johnson executive Hajar Shirley was working on her doctorate, ...
RZV offers substantial clinical and economic benefits but has low uptake among adults aged 50 and older compared to other vaccines. By 2020, only 10.8% of adults aged 50 and older had completed both ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback